Evidence map›Paper›PMID 25893989›Full record

ArticlePloS one2015

Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi.

Artem S Rogovskyy, Timothy Casselli, Yvonne Tourand, Cami R Jones, Jeb P Owen, Kathleen L Mason, Glen A Scoles, Troy Bankhead

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Prevalence and Risk Factors ofPathogens (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. DifferentiatingInfection and immunity · 2025
    Article
  9. Adaptive immunity inApplied and environmental microbiology · 2024
    Article
  10. Article
  11. Hitchhiker's Guide toJournal of bacteriology · 2024
    Review
  12. Comparative reservoir competence ofApplied and environmental microbiology · 2024
    Article
  13. Article
  14. Comparative transcriptome analysis ofFrontiers in cellular and infection microbiology · 2023
    Article
  15. Article
  16. The Brilliance ofPathogens (Basel, Switzerland) · 2021
    Review
  17. Lyme Disease Pathogenesis.Current issues in molecular biology · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Artem S RogovskyyDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America.
Timothy CasselliDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America.
Yvonne TourandDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America.
Cami R JonesDepartment of Entomology, Washington State University, Pullman, Washington, United States of America.
Jeb P OwenDepartment of Entomology, Washington State University, Pullman, Washington, United States of America.
Kathleen L MasonAnimal Disease Research Unit, USDA-ARS, Washington State University, Pullman, Washington, United States of America.
Glen A ScolesAnimal Disease Research Unit, USDA-ARS, Washington State University, Pullman, Washington, United States of America.
Troy BankheadDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington, United States of America; Paul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, United States of America.
Washington State University · US

Funding

Study of Immune Avoidance During the Enzootic Cycle of the Lyme Disease PathogenR01AI108704 · NIAID · WASHINGTON STATE UNIVERSITY · PI BANKHEAD, TROY MICHAEL · 2014 to 2018
$1.3M
NIAID NIH HHS 1R01AI108704NIAID NIH HHS R01 AI108704
6 · The paper itself

Abstract

Efficient acquisition and transmission of Borrelia burgdorferi by the tick vector, and the ability to persistently infect both vector and host, are important elements for the life cycle of the Lyme disease pathogen. Previous work has provided strong evidence implicating the significance of the vls locus for B. burgdorferi persistence. However, studies involving vls mutant clones have thus far only utilized in vitro-grown or host-adapted spirochetes and laboratory strains of mice. Additionally, the effects of vls mutation on tick acquisition and transmission has not yet been tested. Thus, the importance of VlsE antigenic variation for persistent infection of the natural reservoir host, and for the B. burgdorferi enzootic life cycle in general, has not been examined to date. In the current work, Ixodes scapularis and Peromyscus maniculatus were infected with different vls mutant clones to study the importance of the vls locus for the enzootic cycle of the Lyme disease pathogen. The findings highlight the significance of the vls system for long-term infection of the natural reservoir host, and show that VlsE antigenic variability is advantageous for efficient tick acquisition of B. burgdorferi from the mammalian reservoir. The data also indicate that the adaptation state of infecting spirochetes influences B. burgdorferi avoidance from host antibodies, which may be in part due to its respective VlsE expression levels. Overall, the current findings provide the most direct evidence on the importance of VlsE for the enzootic cycle of Lyme disease spirochetes, and underscore the significance of VlsE antigenic variation for maintaining B. burgdorferi in nature.

Indexed as

AnimalsAntigenic VariationAntigens, BacterialBacterial ProteinsBorrelia burgdorferiIxodesLipoproteinsLyme DiseaseMiceMice, Inbred C3HMice, SCIDMutationPeromyscusPolymerase Chain ReactionAntigens, BacterialBacterial ProteinsLipoproteinsVlsE protein, Borrelia burgdorferi

Identifiers

PMID25893989
PMCPMC4404307
OpenAlexW2037400892

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.